Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
History
Further supporting evi
HLA and KIR Associatio
Medicaid and Medicare
msaABCR operon is invo
See All (4) pages
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Medicaid and Medicare Part B spending on immunomodulators and biosimilars.
Thompson AM, Atluri S, Price KN, Hsiao JL, Shi VY. Medicaid and Medicare Part B spending on immunomodulators and biosimilars. J Dermatolog Treat. 2022 May; 33(3):1762-1764.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Aged
Biosimilar Pharmaceuticals
Humans
Immunologic Factors
Medicaid
Medicare Part B
Medicare Part D
United States
Medicaid and Medicare Part B spending on immunomodulators and biosimilars.